Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing AntibodiesLi, Ming ; Gao, Feng ; Mascola, John R ; Stamatatos, Leonidas ; Polonis, Victoria R ; Koutsoukos, Marguerite ; Voss, Gerald ; Goepfert, Paul ; Gilbert, Peter ; Greene, Kelli M ; Bilska, Miroslawa ; Kothe, Denise L ; Salazar-Gonzalez, Jesus F ; Wei, Xiping ; Decker, Julie M ; Hahn, Beatrice H ; Montefiori, David CJournal of Virology, 2005-08, Vol.79 (16), p.10108-10125 [Periódico revisado por pares]Washington, DC: American Society for MicrobiologyTexto completo disponível |
|
2 |
Material Type: Artigo
|
rAd5/NYVAC-B is superior to NYVAC-B/rAd5 and is dependent on rAd5 dose for neutralizing antibody responses against HIV-1Montefiori, DC ; Huang, Y ; Karuna, S ; Allen, M ; Kochar, N ; Chappuis, S ; Gaillard, J ; Tomaras, G ; Graham, B ; Bart, P ; Pantaleo, GRetrovirology, 2012-09, Vol.9 (S2), p.P132-P132, Article P132 [Periódico revisado por pares]London: BioMed CentralTexto completo disponível |
|
3 |
Material Type: Artigo
|
Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoproteinAlexander, J ; Gurwith, M ; Mendy, J ; Vang, L ; Manayani, D ; Avanzini, J ; Guenther, B ; Farness, P ; Haynes, BF ; Liao, H ; Montefiori, DC ; LaBranche, CC ; Mayall, TRetrovirology, 2012-09, Vol.9 (S2), p.P35-P35, Article P35 [Periódico revisado por pares]London: BioMed CentralTexto completo disponível |
|
4 |
Material Type: Artigo
|
Optimization and validation of the HIV-1 neutralizing antibody assay in A3R5 cellsSarzotti-Kelsoe, M ; Daniell, X ; Todd, CA ; Bilska, M ; LaBranche, C ; Perez, LG ; Ochsenbauer, C ; Kappes, J ; Rountree, W ; Ozaki, DA ; Kim, JH ; McLinden, R ; Denny, T ; Montefiori, DCRetrovirology, 2012-09, Vol.9 (S2), p.P69-P69, Article P69 [Periódico revisado por pares]London: BioMed CentralTexto completo disponível |
|
5 |
Material Type: Artigo
|
Robust Neutralizing Antibodies Elicited by HIV-1 JRFL Envelope Glycoprotein Trimers in Nonhuman PrimatesChakrabarti, Bimal K ; Feng, Yu ; Sharma, Shailendra Kumar ; McKee, Krisha ; Karlsson Hedestam, Gunilla B ; Labranche, Celia C ; Montefiori, David C ; Mascola, John R ; Wyatt, Richard TJournal of Virology, 2013-12, Vol.87 (24), p.13239-13251 [Periódico revisado por pares]United States: American Society for MicrobiologyTexto completo disponível |
|
6 |
Material Type: Artigo
|
P11-07. Characterization of a new TZM-bl cell line that expresses human FcαR(CD89)Perez, LG ; Costa, MR ; Montefiori, DCRetrovirology, 2009-10, Vol.6 (S3), p.P152-P152, Article P152 [Periódico revisado por pares]BioMed Central LtdTexto completo disponível |
|
7 |
Material Type: Artigo
|
Isolation of a clonal lineage of IgA broadly neutralizing antibodies from a chronically infected Tanzanian subjectMoody, M ; Drinker, MS ; Gurley, TC ; Amos, JD ; Eudailey, JA ; Armand, LC ; Parks, R ; Gray, ES ; Morris, L ; Finzi, A ; Yang, X ; Sodroski, J ; Liao, H ; Tomaras, GD ; Montefiori, DC ; Haynes, BFRetrovirology, 2012-09, Vol.9 (S2), p.O35-O35, Article O35 [Periódico revisado por pares]London: BioMed CentralTexto completo disponível |
|
8 |
Material Type: Artigo
|
Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial preferentially use the VH1 gene familyBonsignori, M ; Pollara, J ; Moody, MA ; Kepler, TB ; Chen, X ; Gurley, TC ; Kozink, DM ; Marshall, DJ ; Whitesides, JF ; Kaewkungwal, J ; Nitayaphan, S ; Pitisuttithum, P ; Rerks-Ngarm, S ; Kim, JH ; Michael, NL ; Montefiori, DC ; Liao, H ; Ferrari, G ; Haynes, BFRetrovirology, 2012-09, Vol.9 (S2), p.P78-P78, Article P78 [Periódico revisado por pares]London: BioMed CentralTexto completo disponível |
|
9 |
Material Type: Artigo
|
Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trialWilliams, WB ; Jones, K ; Krambrink, A ; Grove, D ; Liu, P ; Yates, NL ; Moody, MA ; Ferrari, G ; Pollara, J ; Moodie, Z ; Morgan, CA ; Liao, H ; Montefiori, DC ; Ochsenbauer, C ; Kappes, J ; Hammer, S ; Mascola, J ; Koup, R ; Corey, L ; Nabel, G ; Gilbert, P ; Churchyard, G ; Keefer, M ; Graham, BS ; Haynes, BF ; Tomaras, GDRetrovirology, 2012-09, Vol.9 (S2), p.O55-O55, Article O55 [Periódico revisado por pares]London: BioMed CentralTexto completo disponível |
|
10 |
Material Type: Artigo
|
Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV – depending on IgG doseSholukh, AM ; Siddappa, NB ; Shanmuganathan, V ; Lakhashe, SK ; Rasmussen, RA ; Watkins, JD ; Vyas, HK ; Mukhtar, MM ; Hemashettar, G ; Thorat, S ; Yoon, JK ; Villinger, F ; Novembre, FJ ; Landucci, G ; Forthal, DN ; Ratcliffe, S ; Robert-Guroff, M ; Polonis, V ; Montefiori, DC ; Ertl, HC ; Ruprecht, RMRetrovirology, 2012-09, Vol.9 (S2), p.P41-P41, Article P41 [Periódico revisado por pares]London: BioMed CentralTexto completo disponível |